Evidence map›Paper›PMID 41012515›Full record

ArticlePharmaceutics2025

Identification of Variable Lymphocyte Receptors That Target the Human Blood-Brain Barrier.

Moriah E Katt, Elizabeth A Waters, Benjamin D Gastfriend, Brantley R Herrin, Max D Cooper, Eric V Shusta

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Moriah E KattDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0002-5958-0412
Elizabeth A WatersDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.
Benjamin D GastfriendDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0002-4677-1455
Brantley R HerrinDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.
Max D CooperDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.
Eric V ShustaDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
Characterization of the Lamprey Adaptive Immune SystemR01AI072435 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Max Dale Cooper · 2007 to 2026
$8.1M
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug DeliveryR01NS099158 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SHUSTA, ERIC V · 2017 to 2021
$1.7M
NHGRI NIH HHS T32 HG002760NIAID NIH HHS R01 AI072435NIGMS NIH HHS T32 GM008349NIH HHS 5R01NS099158-05NIH HHS 5T32GM008349-29NIH HHS 5T32HG002760-19NINDS NIH HHS R01 NS099158
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood–brain barrierbrain drug deliveryvariable lymphocyte receptor

Identifiers

PMID41012515
PMCPMC12473985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.